Evidence map›Paper›PMID 28574488›Full record

Trial reportBlood cancer journal2017

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial.

M Hunault-Berger, N Maillard, C Himberlin, C Recher, A Schmidt-Tanguy, B Choufi, C Bonmati, M Carré, M-A Couturier, E Daguindau and 21 more

Registry-linked trialOpen access · goldAbstract readClinical Trial, Phase IIMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Blood cancer journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05042531 (Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05042531 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia

TypeinterventionalSponsorLanZhou UniversityRan2021 to 2023Enrolled30ConditionsAcute Myeloid LeukemiaArmsAzacitidine, Dasatinib
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 20 institutions in 1 country.

M Hunault-BergerMaladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
N MaillardService d'Hématologie, CHU Poitiers, Poitiers, France.
C HimberlinService d'Hématologie, CHU Reims, Reims, France.
C RecherHématologie Clinique, CHU, Institut Universitaire du Cancer Toulouse-Oncopole, CRCT UMR1037, Université de Toulouse III, Toulouse, France.
A Schmidt-TanguyMaladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
B ChoufiService d'Hématologie, CH Boulogne, Boulogne, France.
C BonmatiService d'Hématologie, CHU Nancy, Nancy, France.
M CarréService d'Hématologie, UMR 5525, CHU Grenoble Alpes, La Tronche, France.
M-A CouturierInstitut d'Hématologie et de Cancérologie, Hôpital Augustin Morvan, Brest, France.
E DaguindauService d'Hématologie, CHU Besançon, Besançon, France.
J-P MarolleauService d'Hématologie, CHU Amiens, Amiens, France.
F Orsini-PiocelleService d'Hématologie, CH Annecy, Annecy, France.
J DelaunayService d'Hématologie, CHU Nantes, Nantes, France.
E TavernierService d'Hématologie, Institut de Cancérologie de la Loire, Saint Etienne, France.
S LissandreService d'Hématologie et thérapie cellulaire, CHU, Tours, France.
M Ojeda-UribeService d'Hématologie, CH Mulhouse, Mulhouse, France.
L SanhesService d'Hématologie, CH Perpignan, Perpignan, France.
L SuttonService d'Hématologie, CH Argenteuil, Argenteuil, France.
A BanosService d'Hématologie, CH Côte Basque, Bayonne, France.
L M ForneckerDépartement d'Hématologie et d'Oncologie, CHU Hautepierre, Strasbourg, France.
M BernardHématologie Clinique, Hôpital Pontchaillou, Rennes, France.
D BouscaryHématologie Clinique, Hôpital Cochin, APHP, Paris, France.
A SaadHématologie, CH Béziers, Béziers, France.
M PuyadeService d'Hématologie, CHU Poitiers, Poitiers, France.ORCID 0000-0002-5639-0138
V RouilléService Hématologie, Hôpital Lapeyronie, Montpellier, France.
I LuquetHématologie Biologique, CHU, IUC Toulouse-Oncopole, Toulouse, France.
M C BénéHématologie Biologique, CHU de Nantes, Nantes, France.
J-F HamelMaladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
F DreyfusHématologie Clinique, Hôpital Cochin, APHP, Paris, France.
N IfrahMaladies du Sang, CHU Angers, CRCINA, INSERM, Université de Nantes, Université d'Angers, Angers, France.
A PigneuxHématologie Clinique, CHU Bordeaux, Inserm 1035, Bordeaux, France.
Inserm · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Poitiers · FRHôpital Cochin · FRCentre Hospitalier de Béziers · FRCentre Hospitalier de la Côte Basque · FRCentre Hospitalier de Mulhouse · FRCentre Hospitalier de Perpignan · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Besançon · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Reims · FRCentre Hospitalier Universitaire de Tours · FRCentre Hospitalier Victor Dupouy · FRHôpital d'Hautepierre · FRHôpital Lapeyronie · FRHôpital Pontchaillou · FRInstitut universitaire du cancer de Toulouse Oncopole · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Maintenance ChemotherapyAgedAged, 80 and overAzacitidineDisease-Free SurvivalFemaleHumansLenalidomideLeukemia, Myeloid, AcuteMaleMiddle AgedSurvival RateThalidomideAzacitidineLenalidomideThalidomide

Identifiers

PMID28574488
PMCPMC5520397
OpenAlexW2620608553

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.